Milestone Scientific (MLSS) Income from Non-Controlling Interests (2015 - 2023)
Milestone Scientific (MLSS) posted Income from Non-Controlling Interests of -$17856.0 for Q4 2023, down 82.0% sequentially from -$9811.0 in Q3 2023, and down 40.54% YoY from -$30031.8 in Q4 2022.
Milestone Scientific (MLSS) Income from Non-Controlling Interests (2015 - 2023) Analysis & Trends
Milestone Scientific has reported Income from Non-Controlling Interests for 9 years, with the latest figure at -$17856.0 in Q4 2023.
- Quarterly Income from Non-Controlling Interests fell 40.54% year-over-year to -$17856.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$17856.0 (up 61.76% YoY) and the FY2023 annual result came in at -$51843.0, up 22.32% from the prior year.
- Income from Non-Controlling Interests fell to -$17856.0 in Q4 2023 per MLSS's latest filing, from -$9811.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at -$9811.0 in Q3 2023 and troughed at -$22848.0 in Q2 2022.
- A 5-year average of -$14205.2 and a median of -$12839.5 in 2019 frame the typical range for Income from Non-Controlling Interests.
- The widest YoY moves for Income from Non-Controlling Interests: up 89.7% in 2019, down 70.99% in 2019.
- Over 5 years, Income from Non-Controlling Interests stood at -$20529.0 in 2019, then rose by 21.88% to -$16038.0 in 2020, then dropped by 3.35% to -$16575.0 in 2021, then rose by 23.35% to -$12705.0 in 2022, then plunged by 40.54% to -$17856.0 in 2023.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$17856.0, -$9811.0, and -$12511.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 79.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Milestone Scientific | 41.18 Mn | 38.57 Mn | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -17,856.00 |
| Sep 30, 2023 | -9,811.00 |
| Jun 30, 2023 | -12,511.00 |
| Mar 31, 2023 | -11,665.00 |
| Dec 31, 2022 | -12,705.00 |
| Sep 30, 2022 | -13,680.00 |
| Jun 30, 2022 | -22,848.00 |
| Mar 31, 2022 | -17,502.00 |
| Dec 31, 2021 | -16,575.00 |
| Sep 30, 2021 | -12,227.00 |
| Jun 30, 2021 | -16,325.00 |
| Mar 31, 2021 | -12,988.00 |
| Dec 31, 2020 | -16,038.00 |
| Sep 30, 2020 | -11,025.00 |
| Jun 30, 2020 | -11,738.00 |
| Mar 31, 2020 | -12,738.00 |
| Dec 31, 2019 | -20,529.00 |
| Sep 30, 2019 | -12,941.00 |
| Jun 30, 2019 | -11,959.00 |
| Mar 31, 2019 | -10,443.00 |